TNBC
Term · Oncology and biomedicine · MLC-T-ONC-008740
A type of breast cancer in which the tumor cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface. Knowing whether breast cancer is triple negative is important in planning treatment. Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer.
TNBC is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer.
| Identifier | MLC-T-ONC-008740 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | ER-negative PR-negative HER2/neu-negative breast cancer; triple-negative breast cancer |
| References | NCI Dictionary of Cancer Terms; NCI Dictionary of Genetics Terms |
Record as JSON
{
"id": "MLC-T-ONC-008740",
"term": "TNBC",
"field": "Oncology and biomedicine",
"definitions": [
"A type of breast cancer in which the tumor cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface. Knowing whether breast cancer is triple negative is important in planning treatment. Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer.",
"TNBC is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called ER-negative PR-negative HER2/neu-negative breast cancer and triple-negative breast cancer."
],
"expansions": [
"ER-negative PR-negative HER2/neu-negative breast cancer",
"triple-negative breast cancer"
],
"references": [
"NCI Dictionary of Cancer Terms",
"NCI Dictionary of Genetics Terms"
],
"url": "https://mlchart.com/terminology/oncology/tnbc/"
}
Record 16,443 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.